Acronyms And Abbreviations |
|
xix | |
|
|
1 | (6) |
|
|
3 | (1) |
|
Organization of the Proceedings of the Workshop |
|
|
4 | (3) |
|
2 The Economics Of Global Health And Microbial Threats |
|
|
7 | (6) |
|
Perspectives on Priorities for Using Economics for Global Health |
|
|
7 | (4) |
|
Reflections from the Keynote Presentation |
|
|
11 | (2) |
|
3 The Economic Cost Of Endemic Infectious Diseases |
|
|
13 | (16) |
|
Economic Case for Eradicating Polio |
|
|
13 | (3) |
|
Economic Impact of HIV/AIDS |
|
|
16 | (3) |
|
Costs and Value of Tuberculosis Control |
|
|
19 | (3) |
|
|
22 | (7) |
|
4 The Economics And Modeling Of Emerging Infectious Diseases And Biological Risks |
|
|
29 | (18) |
|
Cost of Pandemic Influenza |
|
|
29 | (3) |
|
Assessing Economic Vulnerability to Emerging Infectious Disease Outbreaks |
|
|
32 | (3) |
|
Epidemic Risk Modeling: Measuring the Effect of Aversion |
|
|
|
Behavior and Cascading Social Responses |
|
|
35 | (2) |
|
Impact and Future of Global Catastrophic Biological Risks |
|
|
37 | (4) |
|
|
41 | (6) |
|
5 The Cost Dimensions Of Antimicrobial Resistance |
|
|
47 | (14) |
|
Considerations for Estimating the Cost of Antimicrobial Resistance: Direct Versus Indirect Costs |
|
|
47 | (4) |
|
Cost-Effectiveness of Interventions to Limit the Spread of Antimicrobial Resistance: A Perspective from OECD |
|
|
51 | (2) |
|
Reconceptualizing Antimicrobial Resistance to Build the Investment Case |
|
|
53 | (2) |
|
|
55 | (6) |
|
6 Investing In National Preparedness Initiatives Against Microbial Threats |
|
|
61 | (14) |
|
Epidemic Preparedness: Lessons from Liberia |
|
|
62 | (2) |
|
Potential Challenges and Opportunities for Investing in National-Level Preparedness |
|
|
64 | (2) |
|
Using the Performance of Veterinary Services Pathway to Bolster Preparedness |
|
|
66 | (2) |
|
Costs and Benefits of Implementing a One Health Approach Against Microbial Threats |
|
|
68 | (2) |
|
|
70 | (5) |
|
7 Accelerating Research And Development Of Antimicrobial Medical Products |
|
|
75 | (12) |
|
Commercial Perspectives on Opportunities and Barriers to Discovery and Development of Antimicrobials |
|
|
75 | (6) |
|
|
81 | (6) |
|
8 Reimagining Sustainable Investments To Counter Microbial Threats |
|
|
87 | (10) |
|
Economics of International Collective Action to Counter Microbial Threats |
|
|
87 | (3) |
|
Overcoming Economic Bottlenecks in Delivering Medical Products to Address Microbial Threats Across Africa |
|
|
90 | (4) |
|
|
94 | (3) |
|
9 Looking To The Future: Potential Next Steps For Using Economics To Manage Microbial Threats |
|
|
97 | (14) |
|
Modeling the Economics of Emerging Infectious Diseases |
|
|
98 | (1) |
|
Stimulating Research and Development for Antimicrobials |
|
|
99 | (3) |
|
Incentivizing National Governments to Invest in Preparedness |
|
|
102 | (3) |
|
Synthesis and General Discussion |
|
|
105 | (6) |
|
|
111 | (4) |
|
Research, Convenings, and Policy |
|
|
111 | (1) |
|
|
112 | (11) |
References |
|
115 | (8) |
Appendixes |
|
|
A Workshop Statement Of Task |
|
|
123 | (2) |
|
|
125 | (6) |
|
C Biographical Sketches Of Workshop Speakers And Moderators |
|
|
131 | |